Cargando…

Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic

Background and Objectives: Urosepsis is a significant cause of maternal and fetal mortality. While certain risk factors for urinary tract infections (UTIs) in pregnant women are well established, those associated with an elevated risk of urosepsis in pregnant women with upper UTIs remain less define...

Descripción completa

Detalles Bibliográficos
Autores principales: Radu, Viorel Dragos, Costache, Radu Cristian, Onofrei, Pavel, Antohi, Liviu, Bobeica, Razvan Lucian, Linga, Iacov, Tanase-Vasilache, Ingrid, Ristescu, Anca Irina, Murgu, Alina-Mariela, Miftode, Ionela-Larisa, Stoica, Bogdan Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673142/
https://www.ncbi.nlm.nih.gov/pubmed/38004021
http://dx.doi.org/10.3390/medicina59111972
_version_ 1785140553157967872
author Radu, Viorel Dragos
Costache, Radu Cristian
Onofrei, Pavel
Antohi, Liviu
Bobeica, Razvan Lucian
Linga, Iacov
Tanase-Vasilache, Ingrid
Ristescu, Anca Irina
Murgu, Alina-Mariela
Miftode, Ionela-Larisa
Stoica, Bogdan Alexandru
author_facet Radu, Viorel Dragos
Costache, Radu Cristian
Onofrei, Pavel
Antohi, Liviu
Bobeica, Razvan Lucian
Linga, Iacov
Tanase-Vasilache, Ingrid
Ristescu, Anca Irina
Murgu, Alina-Mariela
Miftode, Ionela-Larisa
Stoica, Bogdan Alexandru
author_sort Radu, Viorel Dragos
collection PubMed
description Background and Objectives: Urosepsis is a significant cause of maternal and fetal mortality. While certain risk factors for urinary tract infections (UTIs) in pregnant women are well established, those associated with an elevated risk of urosepsis in pregnant women with upper UTIs remain less defined. This study aims to identify factors linked to an increased risk of urosepsis and examine urologic treatment outcomes in such cases. Materials and Methods: We conducted a retrospective analysis on 66 pregnant women diagnosed with urosepsis over a nine-year period. A control group included 164 pregnant women with upper UTIs, excluding urosepsis, admitted during the same timeframe. This study highlights factors potentially contributing to urosepsis risk, including comorbidities like anemia, pregnancy-related hydronephrosis or secondary to reno-ureteral lithiasis, prior UTIs, coexisting urological conditions, and urologic procedures. Outcomes of urologic treatments, hospitalization duration, obstetric transfers due to fetal distress, and complications associated with double-J catheters were analyzed. Results: Pregnant women with urosepsis exhibited a higher prevalence of anemia (69.7% vs. 50.0%, p = 0.006), 2nd–3rd grade hydronephrosis (81.8% vs. 52.8%, p = 0.001), and fever over 38 °C (89.4% vs. 42.1%, p = 0.001). They also had a more intense inflammatory syndrome (leukocyte count 18,191 ± 6414 vs. 14,350 ± 3860/mmc, p = 0.001, and C-reactive protein (CRP) 142.70 ± 83.50 vs. 72.76 ± 66.37 mg/dL, p = 0.001) and higher creatinine levels (0.77 ± 0.81 vs. 0.59 ± 0.22, p = 0.017). On multivariate analysis, factors associated with increased risk for urosepsis were anemia (Odds Ratio (OR) 2.622, 95% CI 1.220–5.634), 2nd–3rd grade hydronephrosis (OR 6.581, 95% CI 2.802–15.460), and fever over 38 °C (OR 11.612, 95% CI 4.804–28.07). Regarding outcomes, the urosepsis group had a higher rate of urological maneuvers (87.9% vs. 36%, p = 0.001), a higher rate of obstetric transfers due to fetal distress (22.7% vs. 1.2%, p = 0.001), and migration of double-J catheters (6.1% vs. 0.6%, p = 0.016), but no maternal fatality was encountered. However, they experienced the same rate of total complications related to double-J catheters (19.69% vs. 12.80%, p > 0.05). The pregnant women in both groups had the infection more frequently on the right kidney, were in the second trimester and were nulliparous. Conclusions: Pregnant women at increased risk for urosepsis include those with anemia, hydronephrosis due to gestational, or reno-ureteral lithiasis, and fever over 38 °C. While the prognosis for pregnant women with urosepsis is generally favorable, urological intervention may not prevent a higher incidence of fetal distress and the need for obstetric transfers compared to pregnant women with uncomplicated upper UTIs.
format Online
Article
Text
id pubmed-10673142
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106731422023-11-08 Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic Radu, Viorel Dragos Costache, Radu Cristian Onofrei, Pavel Antohi, Liviu Bobeica, Razvan Lucian Linga, Iacov Tanase-Vasilache, Ingrid Ristescu, Anca Irina Murgu, Alina-Mariela Miftode, Ionela-Larisa Stoica, Bogdan Alexandru Medicina (Kaunas) Article Background and Objectives: Urosepsis is a significant cause of maternal and fetal mortality. While certain risk factors for urinary tract infections (UTIs) in pregnant women are well established, those associated with an elevated risk of urosepsis in pregnant women with upper UTIs remain less defined. This study aims to identify factors linked to an increased risk of urosepsis and examine urologic treatment outcomes in such cases. Materials and Methods: We conducted a retrospective analysis on 66 pregnant women diagnosed with urosepsis over a nine-year period. A control group included 164 pregnant women with upper UTIs, excluding urosepsis, admitted during the same timeframe. This study highlights factors potentially contributing to urosepsis risk, including comorbidities like anemia, pregnancy-related hydronephrosis or secondary to reno-ureteral lithiasis, prior UTIs, coexisting urological conditions, and urologic procedures. Outcomes of urologic treatments, hospitalization duration, obstetric transfers due to fetal distress, and complications associated with double-J catheters were analyzed. Results: Pregnant women with urosepsis exhibited a higher prevalence of anemia (69.7% vs. 50.0%, p = 0.006), 2nd–3rd grade hydronephrosis (81.8% vs. 52.8%, p = 0.001), and fever over 38 °C (89.4% vs. 42.1%, p = 0.001). They also had a more intense inflammatory syndrome (leukocyte count 18,191 ± 6414 vs. 14,350 ± 3860/mmc, p = 0.001, and C-reactive protein (CRP) 142.70 ± 83.50 vs. 72.76 ± 66.37 mg/dL, p = 0.001) and higher creatinine levels (0.77 ± 0.81 vs. 0.59 ± 0.22, p = 0.017). On multivariate analysis, factors associated with increased risk for urosepsis were anemia (Odds Ratio (OR) 2.622, 95% CI 1.220–5.634), 2nd–3rd grade hydronephrosis (OR 6.581, 95% CI 2.802–15.460), and fever over 38 °C (OR 11.612, 95% CI 4.804–28.07). Regarding outcomes, the urosepsis group had a higher rate of urological maneuvers (87.9% vs. 36%, p = 0.001), a higher rate of obstetric transfers due to fetal distress (22.7% vs. 1.2%, p = 0.001), and migration of double-J catheters (6.1% vs. 0.6%, p = 0.016), but no maternal fatality was encountered. However, they experienced the same rate of total complications related to double-J catheters (19.69% vs. 12.80%, p > 0.05). The pregnant women in both groups had the infection more frequently on the right kidney, were in the second trimester and were nulliparous. Conclusions: Pregnant women at increased risk for urosepsis include those with anemia, hydronephrosis due to gestational, or reno-ureteral lithiasis, and fever over 38 °C. While the prognosis for pregnant women with urosepsis is generally favorable, urological intervention may not prevent a higher incidence of fetal distress and the need for obstetric transfers compared to pregnant women with uncomplicated upper UTIs. MDPI 2023-11-08 /pmc/articles/PMC10673142/ /pubmed/38004021 http://dx.doi.org/10.3390/medicina59111972 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Radu, Viorel Dragos
Costache, Radu Cristian
Onofrei, Pavel
Antohi, Liviu
Bobeica, Razvan Lucian
Linga, Iacov
Tanase-Vasilache, Ingrid
Ristescu, Anca Irina
Murgu, Alina-Mariela
Miftode, Ionela-Larisa
Stoica, Bogdan Alexandru
Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic
title Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic
title_full Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic
title_fullStr Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic
title_full_unstemmed Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic
title_short Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic
title_sort factors associated with increased risk of urosepsis during pregnancy and treatment outcomes, in a urology clinic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673142/
https://www.ncbi.nlm.nih.gov/pubmed/38004021
http://dx.doi.org/10.3390/medicina59111972
work_keys_str_mv AT raduvioreldragos factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT costacheraducristian factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT onofreipavel factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT antohiliviu factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT bobeicarazvanlucian factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT lingaiacov factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT tanasevasilacheingrid factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT ristescuancairina factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT murgualinamariela factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT miftodeionelalarisa factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic
AT stoicabogdanalexandru factorsassociatedwithincreasedriskofurosepsisduringpregnancyandtreatmentoutcomesinaurologyclinic